iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Stock Price Up 0.6% – Here’s Why

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA)’s stock price rose 0.6% on Thursday . The company traded as high as $22.99 and last traded at $22.96. Approximately 38,357 shares traded hands during trading, an increase of 15% from the average daily volume of 33,216 shares. The stock had previously closed at $22.83.

iShares Genomics Immunology and Healthcare ETF Stock Up 0.6 %

The stock has a market cap of $134.32 million, a P/E ratio of 2.29 and a beta of 1.14. The business’s 50-day simple moving average is $23.97 and its two-hundred day simple moving average is $24.14.

Institutional Investors Weigh In On iShares Genomics Immunology and Healthcare ETF

An institutional investor recently bought a new position in iShares Genomics Immunology and Healthcare ETF stock. Avior Wealth Management LLC bought a new position in iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor bought 9,500 shares of the company’s stock, valued at approximately $234,000. Avior Wealth Management LLC owned approximately 0.16% of iShares Genomics Immunology and Healthcare ETF at the end of the most recent reporting period.

About iShares Genomics Immunology and Healthcare ETF

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.